The U.S. market for penicillins and streptomycins is anticipated to grow from $4.3622 billion in 2024 to $4.4648 billion in 2028. From 2024 to 2028, the market is expected to experience a steady year-on-year growth with CAGR around 0.58%. The market in 2023 stood at a slightly lower value, around $4.34 billion, demonstrating consistent growth over the forecast period.
Future trends to watch:
- Increased demand for antibiotics in healthcare due to resistant infections.
- Potential innovations in drug formulations enhancing efficiency.
- Regulatory changes affecting market dynamics and pricing.
